Protokinetix Inc (PKTX) financial statements (2021 and earlier)

Company profile

Business Address 412 MULBERRY STREET
MARIETTA, OH 45750
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37713630337137103
Cash and cash equivalents37713630337137103
Receivables    850
Prepaid expense1162700 21
Total current assets:378137365441379625
Noncurrent Assets
Intangible assets, net (including goodwill)20818815310170 
Intangible assets, net (excluding goodwill)20818815310170  
Total noncurrent assets:20818815310170  
TOTAL ASSETS:586325518542450625
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2679274545271174
Accrued liabilities     82
Other undisclosed accounts payable and accrued liabilities2679274545263172
Debt  118  227571
Total current liabilities:26791454545497745
Noncurrent Liabilities
Long-term debt and lease obligation     84 
Long-term debt, excluding current maturities     84 
Total noncurrent liabilities:     84 
Other undisclosed liabilities     (147)(103)
Total liabilities:26791454545434643
Stockholders' equity
Stockholders' equity attributable to parent, including:560246374497404(428)(618)
Common stock1111111
Common stock, value, subscriptions     25
Additional paid in capital36,10731,59530,50629,11627,49925,41225,028
Accumulated deficit(35,548)(31,350)(30,134)(28,620)(27,096)(25,841) 
Other undisclosed stockholders' equity attributable to parent     (25)(25,647)
Total stockholders' equity:560246374497404(428)(618)
TOTAL LIABILITIES AND EQUITY:586325518542450625

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues
(Other Income)
     250 
Cost of revenue
(Cost of Goods and Services Sold)
    (125)(95)(213)
Gross profit:    (125)155(213)
Operating expenses(4,198)(1,216)(1,514)(1,525)(1,262)(419)(449)
Operating loss:(4,198)(1,216)(1,514)(1,525)(1,387)(264)(662)
Interest and debt expense (0)(2)(0)7161(26)
Other undisclosed income from continuing operations before equity method investments, income taxes      240
Net loss:(4,198)(1,217)(1,515)(1,525)(1,380)(103)(449)
Other undisclosed net income (loss) attributable to parent 020125(66) 
Net loss available to common stockholders, diluted:(4,198)(1,216)(1,514)(1,525)(1,255)(168)(449)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(4,198)(1,217)(1,515)(1,525)(1,380)(103)(449)
Comprehensive loss, net of tax, attributable to parent:(4,198)(1,217)(1,515)(1,525)(1,380)(103)(449)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: